We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Lung Cancer

Journal Scan / Research · February 22, 2021

Subtypes of SCLC With Therapeutic Vulnerabilities

Cancer Cell


Additional Info

Cancer Cell
Patterns of Transcription Factor Programs and Immune Pathway Activation Define Four Major Subtypes of SCLC With Distinct Therapeutic Vulnerabilities
Cancer Cell 2021 Jan 21;[EPub Ahead of Print], CM Gay, CA Stewart, EM Park, L Diao, SM Groves, S Heeke, BY Nabet, J Fujimoto, LM Solis, W Lu, Y Xi, RJ Cardnell, Q Wang, G Fabbri, KR Cargill, NI Vokes, K Ramkumar, B Zhang, CM Della Corte, P Robson, SG Swisher, JA Roth, BS Glisson, DS Shames, II Wistuba, J Wang, V Quaranta, J Minna, JV Heymach, LA Byers

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading